Navigation Links
Cato Research Presents at Korea-Maryland, USA BIO EXPO, Drug Development Process and Regulatory Approaches
Date:11/7/2013

Durham, NC (PRWEB) November 07, 2013

Cato Research clinical research physician and managing director for Cato Research’s Washington office, Jack Snyder, M.D., Ph.D., R.A.C., D.A.B.T., C.P.I., and Cato Research regulatory expert Elinore M. Mercer, Ph.D., R.A.C., will present in Rockville, Maryland, at the Korea-Maryland, United States of America Bio Expo, Drug Development Process and Regulatory Approaches.    

Dr. Jack Snyder will present the following sessions:

Session 1: “IND Process – Nonclinical”
1. Pharmacology and Toxicity Study Design and Guidance
2. Case Studies in Pharmacology and Toxicology

Session 2: “CMC Process”
1. USP Identification Standards
2. Chemistry Section
3. Specifications for CMC / CMC
4. FDA Pertinent Guidance

Session 3: “Pharmacometrics and Clinical Trials Design”
1. Data Analysis, Pharmacometrics and Clinical Trial Design Statistical Methodology for Design
2. and Evaluation of Clinical Trials
3. Use of SAS, Population Modeling, PK/PD Modeling
4. Case Studies and Pertinent FDA Guidances

Dr. Elinore Mercer will copresent Friday, November 8th on the following:

Session 7: "Innovative Strategies for New Drug Development"
1. Current Initiatives for Repurposing Pharmaceuticals and New Development
2. Biosimilar Strategies and Current Guideline Discussion
3. Biosimilar/Follow-on Biologics; Pertinent FDA Guidance

Dr. Snyder serves as a Clinical Research Physician and managing director for Cato Research’s Washington office as well as a Medical Analyst for Cato BioVentures. Dr. Snyder is a pharmacologist-toxicologist-pathologist with more than 25 years’ experience in academia, government, and industry. Dr. Snyder has experience in diverse areas of business, including project management, policy development, strategic planning, regulatory and safety compliance, intellectual property, and quality control and improvement. He has conducted basic and clinical research, practiced clinical and laboratory medicine, inspected a variety of research and clinical laboratories, and edited or authored more than 120 publications.

Dr. Mercer is a Regulatory Scientist at Cato Research where she crafts regulatory strategies for biologics and drugs based on the ever-changing regulatory environment. Prior to joining Cato Research, Dr. Mercer did her Ph.D. training at the University of California, San Diego, and her post-doctoral work at the Genomics Institute of the Novartis Research Foundation. She also had stints at biotechs Genoptix and Kalypsys, and acts as a scientific analyst for the ventures arm of Cato Research, Cato BioVentures.

For more information about this event, please visit:
http://www.cato.com/events.shtml

About Cato Research
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, North Carolina, Cato Research is a full-service, global contract research and development organization providing strategic and tactical support for clients in the pharmaceutical, biotechnology, and medical device industries. Services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval. With a staff of approximately 300 and offices located in the United States, Europe, Canada, Israel, and South Africa, the Cato Research team consistently demonstrates an unsurpassed level of responsiveness, flexibility, attention to detail, and passion for bringing their clients’ products to market with speed and cost-effectiveness.

For more information, please contact:

Cato Research
Phone: 919-361-2286
http://www.cato.com
# # #

Read the full story at http://www.prweb.com/releases/2013/11/prweb11309105.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Diabetic flies can speed up disease-fighting research
2. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
3. Bend Research to Highlight Latest Drug Formulation Technologies
4. Shocking News & Research: Boston Scientific, Yingli Green Energy Hold, QUALCOMM, PulteGroup, Regions Financial
5. Clinical Research Site-Expert Johan Karlberg to Lead ACRES Global Network Development
6. Global In Vitro Fertilization Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
7. NPL leads research project to help deliver 10x faster computer processing speeds
8. BCC Research Publishes a New Report On Global Markets for Flow Cytometry
9. York researchers discover important mechanism behind nanoparticle reactivity
10. First Annual Michael SanInocencio Lennox-Gastaut Syndrome Research Award Presented at Annual Meeting of the Child Neurology Society
11. Hun School Bio Students Conduct Original Molecular Research in Conjunction with Rutgers University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee is ... honoring scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. ... world’s leading conference and exposition for laboratory science, which will be held February ...
(Date:10/9/2017)... ... , ... The award-winning American Farmer television series will feature 3 Bar Biologics ... at 8:30aET on RFD-TV. , With global population estimates nearing ten billion people ... to feed a growing nation. At the same time, many of our valuable resources ...
Breaking Biology Technology:
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
Breaking Biology News(10 mins):